Spotlight -

B + L Dry Eye Series|

Transforming Glaucoma Management|

Zeiss Clinical Cases

Viewing

|Poll|March 15, 2023

Poll: Will you be attending COPHy in Lisbon, Portugal, from March 24 to 25?

Author(s)Modern Retina Staff

A poll for retina specialists: Let us know if you will attend the 14th annual Congress on Controversies in Ophthalmology.

Will you be attending COPHy in Lisbon, Portugal, from March 24 to 25?

Newsletter

Don’t miss out—get Modern Retina updates delivered straight to your inbox.

Related Content

Mark Barakat, MD | Modern Retina CTS coverage

CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice

ByMark R. Barakat, MD,Lucia Gambuzza

June 15th 2026

(Image credit: Modern Retina) Clinical Trials at the Summit 2026: First-time data, AI, and the next generation of retinal treatments

Clinical Trials at the Summit 2026: First-time data, AI, and the next generation of retinal treatments

ByArshad M. Khanani, MD, MA, FASRS,Sheryl Stevenson

June 9th 2026

(Image credit: AdobeStock/cirquedesprit) Phase 3 data support OTX-TKI's durability in wet AMD: 1 injection, 1 year

Phase 3 data support OTX-TKI's durability in wet AMD: 1 injection, 1 year

ByModern Retina Staff

June 1st 2026

(Image credit: Modern Retina) Retina World Congress 2026: The dopamine-AMD connection

Retina World Congress 2026: The dopamine-AMD connection

BySharon Fekrat, MD, FACS, FASRS,Sheryl Stevenson

May 31st 2026

(Image credit: Modern Retina) Retina World Congress 2026: Dry AMD — Geographic atrophy, photobiomodulation, and the road ahead

Retina World Congress 2026: Dry AMD — Geographic atrophy, photobiomodulation, and the road ahead

ByDimitra Skondra, MD, PhD, FASRS,Sheryl Stevenson

May 31st 2026

Latest CME

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

Trending on Eye Care Network - Ophthalmology Times

Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP

Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial

Retina Society 2026: LUGANO secondary data show reduced treatment burden with vorolanib insert despite missed primary end point

Beyond the phenotype: Aqueous humor sampling moves retinoblastoma toward personalized therapy

EyeCon 2026: Visionary in Eye Care Resident Recognition Award winners announced